Company / Operating Cash Flow
AETHLON MEDICAL INC Operating Cash Flow History
FY2014-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$7.6M
FY2024
5-year range
-$10.5M / -$4.3M
FY2020-FY2024
Trend
+24.5%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$11M to -$8M over the past 2 years.
Based on SEC 10-K filings.
-$8M in FY2024.
Improved from -$11M to -$8M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating cash flow increased 24.5% year-over-year.
- Peak operating cash flow was recorded in FY2014.
- Lowest operating cash flow in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$7.6M | +24.5% |
| FY2023 | -$10.1M | +3.6% |
| FY2022 | -$10.5M | -102.1% |
| FY2021 | -$5.2M | -21.1% |
| FY2020 | -$4.3M | +0.0% |
| FY2018 | -$4.3M | +0.8% |
| FY2017 | -$4.3M | -23.5% |
| FY2016 | -$3.5M | -63.9% |
| FY2015 | -$2.1M | -1.9% |
| FY2014 | -$2.1M | -14.0% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026